ECSP961668A - DNASA I HUMAN VARIANTS - Google Patents

DNASA I HUMAN VARIANTS

Info

Publication number
ECSP961668A
ECSP961668A ECSP961668A ECSP961668A EC SP961668 A ECSP961668 A EC SP961668A EC SP961668 A ECSP961668 A EC SP961668A EC SP961668 A ECSP961668 A EC SP961668A
Authority
EC
Ecuador
Prior art keywords
variants
dnasa
human
dnase
human variants
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert A Lazarus
Steven Shak
Jana S Ulmer
Theodore R Stout
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961668 priority Critical patent/ECSP961668A/en
Publication of ECSP961668A publication Critical patent/ECSP961668A/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

Esta invención está relacionada a los resultados obtenidos en pesquisa deoxiribonucleasa humana I (IDNasa), un fosfodieserasa que es capaz de hidrolizar ácido polideoxiribonucleico. Se relaciona generalmente a formas modificadas (variantes) de la Dnasa I humana y su preparación por métodos de DNA recombinante, para composiciones farmacéuticas por las cuales su utilidad puede ser explotada clinicamente, y métodos de utilizar estas variantes DNasa I y composiciones de la misma, todo según consta en la memoria descrptiva reivindicaciones y dibujos.This invention is related to the results obtained in the investigation of human deoxyribonuclease I (IDNase), a phosphodierase that is capable of hydrolyzing polideoxyribonucleic acid. It is generally related to modified forms (variants) of human Dnase I and their preparation by recombinant DNA methods, for pharmaceutical compositions for which their utility can be clinically exploited, and methods of using these DNase I variants and compositions thereof, all as stated in the descriptive memory claims and drawings.

ECSP961668 1996-02-21 1996-02-21 DNASA I HUMAN VARIANTS ECSP961668A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961668 ECSP961668A (en) 1996-02-21 1996-02-21 DNASA I HUMAN VARIANTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961668 ECSP961668A (en) 1996-02-21 1996-02-21 DNASA I HUMAN VARIANTS

Publications (1)

Publication Number Publication Date
ECSP961668A true ECSP961668A (en) 1997-09-09

Family

ID=42042402

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961668 ECSP961668A (en) 1996-02-21 1996-02-21 DNASA I HUMAN VARIANTS

Country Status (1)

Country Link
EC (1) ECSP961668A (en)

Similar Documents

Publication Publication Date Title
BR9916894A (en) sulfohydroxamic acids and sulfohydroxamates and their use as mek inhibitors
EA199900486A1 (en) APPLICATION OF SPHINGOMYELINASE FOR INCREASING THE LEVELS OF CERAMIDES IN THE SKIN AND MICROSCOPIC SHELLS, AND ALSO CONTAINING ITS DERMATOLOGICAL AND COSMETIC COMPOSITIONS THAT ARE RELIABLE FOR LOCAL APPLICATION
BR9201015A (en) PROTEIN CONJUGATE, COMPOUND, PROCESS TO PREPARE THE CONJUGATE, PHARMACEUTICAL COMPOSITIONS AND USE
AP2001002217A0 (en) 4-IODOPHENYLAMINO BENZHYDROXAMIC ACID OXYGENES ESTERS
PT1254899E (en) PIPERAZINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
ECSP045520A (en) TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
BRPI0413728B8 (en) human tear lipocalin mutein, methods for generating and producing mutein, pharmaceutical composition and use of mutein
EA200300293A1 (en) ANTI-INFLAMMATORY CONDENSED Pyrrolocarbazoles
DE602004014170D1 (en) BENZYL ETHER AND BENZYLAMINO BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
TR200000927T2 (en) Treatment of prostaglandin agonists and bone disorders
PT801649E (en) USEFUL HYDROXYLAMINE DERIVATIVES TO INCREASE THE PRODUCTION OF ADVENTIABLE MOLECULAR PROTEINS AND THEIR PREPARATION
MX9207449A (en) INHIBITORS OF THE PROTEOLYTIC ENZYME DERIVED FROM SACARINE.
AR006188A1 (en) "PHARMACEUTICAL COMPOSITION TO INHIBIT SERINPROTEASE ACTIVITY, IN VITRO METHOD TO INHIBIT SERINPROTEASE ACTIVITY AND METHOD TO PREPARE SUCH COMPOSITION".
BR9911305A (en) Nitrate salts, process for preparing the same, pharmaceutical compositions, and use of them
EP1007556A4 (en) TROPONIN SUBUNITS AND FRAGMENTS USEFUL AS ANGIOGENESIS INHIBITORS
ES2181234T3 (en) COMBINATION PRODUCT THAT ASSOCIATES A NUCLEIC ACID TO A SUBSTANCE THAT DISORGANIZES THE EXTRACELLULAR MATRIX FOR GENE THERAPY.
PT733109E (en) MORPHOGENETIC PROTEINS OF 0SS0S PMO-12 AND PMO-13 AND THEIR COMPOSITIONS FOR TENDAO INDUCTION
AR022888A1 (en) DEFINITIVE MIXING, ITS USE TO CAUSE THE FALL OF THE PLANT LEAVES AND PROCEDURE TO CAUSE THE FALL OF THE PLANT LEAVES
ES2110414T3 (en) SUGAR DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND THEIR PREPARATION.
BR9815409A (en) Thienopyrimidines
EA199700380A1 (en) BICYCLIC AROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS ON THEIR BASIS AND APPLICATION OF COSMETIC COMPOSITIONS
DK284386D0 (en) PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS
BR9702074A (en) Heterocyclic biaryl compounds pharmaceutical and cosmetic compositions containing them and their uses
EA200000165A1 (en) BRANCHED ALCOXYLENE-2-AMINOPYRIDINES AS NOS INHIBITORS
EA199700381A1 (en) DIAROMATIC COMPOUNDS PROPINIL OR DIENIL, INTERMEDIATE CONNECTIONS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THE SPECIFIED CONNECTIONS AND APPLICATION OF COSMETIC COMPOSITIONS